A carregar...
Low serum miR‐223 expression predicts poor outcome in patients with acute myeloid leukemia
BACKGROUND: Identification of biomarkers for acute myeloid leukemia (AML) is important for treating this malignancy. Recent studies have reported that microRNAs (miRNAs) are stably detectable in the blood/plasma and can be used as biomarkers for various types of cancer including AML. The aim of this...
Na minha lista:
| Publicado no: | J Clin Lab Anal |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083432/ https://ncbi.nlm.nih.gov/pubmed/31691380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|